Test Price
2,800 AED✅ Home Collection Available
TYMP Gene MNGIE Syndrome (Without Leukoencephalopathy) Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
Executive Summary: This NGS full-gene sequencing test for the TYMP gene provides precise molecular diagnosis of mitochondrial neurogastrointestinal encephalopathy (MNGIE) syndrome without leukoencephalopathy. The analysis is performed in an ISO 9001:2015 certified laboratory, with VIP mobile phlebotomy and temperature-controlled cold-chain home collection available across all UAE Emirates.
- ✓Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- ✓Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM–11 PM daily).
- ✓Clinical Guidance: Telephonic post-test clinical guidance in result interpretation.
- ✓Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The TYMP Gene NGS Test is a comprehensive next‑generation sequencing analysis that detects mutations causing mitochondrial neurogastrointestinal encephalopathy (MNGIE) syndrome, a rare autosomal recessive disorder. This test uses a simple whole blood sample, extracted DNA, or dried blood spot to provide definitive diagnostic answers.
| Parameter | Our Test | Closest Alternative |
|---|---|---|
| Precision | Full TYMP gene sequencing (all exons & splice sites) | Single‑gene Sanger sequencing (limited coverage) |
| Method | NGS (Next Generation Sequencing) | PCR + Sanger (lower throughput) |
| Turnaround Time | 3 – 4 Weeks | 6 – 8 Weeks |
Pre‑Test Requirements
- Sample: Whole Blood (EDTA tube), Extracted DNA, or Dried Blood Spot on FTA Card.
- Mandatory pre‑genetic counselling session to draw a pedigree chart of family members affected with TYMP Gene MNGIE Syndrome.
- No fasting or medication adjustment required; please carry all relevant medical reports and previous neurological investigations.
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA License: 9294403) advises: “Genetic testing for MNGIE is crucial for confirming a clinical suspicion and enabling life‑saving interventions such as allogeneic stem cell transplantation or enzyme replacement. A negative result does not exclude the disorder if the phenotype is strong; interpretation must integrate neurological, gastrointestinal, and metabolic evaluations. Positive results empower early intervention and family counselling.”
Advisory: Medication Guidance
Do not discontinue prescribed medication without consulting your doctor. This test does not replace ongoing clinical management; any treatment decisions must be made under specialist guidance.
Exclusion Criteria & Safety Precautions
- Exclusion Criteria: This test is not recommended for asymptomatic minors without a family history of MNGIE. Genetic counselling is mandatory per Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- Emergency Red Flags: If the patient develops acute metabolic crisis, severe lactic acidosis, or sudden neurological deterioration, seek immediate emergency care; do not wait for genetic test results.
- Minors: Testing of minors requires explicit consent from a legal guardian, in compliance with Federal Decree‑Law No. 4 of 2016 and the UAE Personal Data Protection Law.
Patient FAQ & Clinical Guidance
1. What is the difference between this genetic test and routine blood tests?
This genetic test identifies the exact mutation in the TYMP gene responsible for MNGIE, providing a definitive molecular diagnosis. Routine blood tests can only detect metabolic abnormalities and cannot confirm the genetic origin of the disease.
2. Can home phlebotomy be arranged across all UAE Emirates?
Yes, we offer VIP Mobile Phlebotomy with temperature‑controlled cold‑chain logistics across Dubai, Abu Dhabi, Sharjah, and all Northern Emirates. Our service is available from 8 AM to 11 PM daily, and samples are handled under ISO compliant conditions.
3. When should the test be repeated or additional tests considered?
A single genetic test is sufficient for a lifetime. However, your specialist may recommend carrier testing for family members, metabolic monitoring, or further investigations if clinical symptoms evolve or if new therapies become available.
UAE Regulatory & Data Privacy Adherence
Regulatory & Data Privacy
- Licensed by DHA (Facility License: 1143).
- ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).
- All data processing complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Your data is securely processed and results are shared only with the ordering physician.
Clinical & Logistical Metadata
| Test Name | TYMP Gene NGS Test for MNGIE Syndrome (Without Leukoencephalopathy) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA tube), Extracted DNA, or Dried Blood Spot (FTA card) |
| Methodology Used | Next Generation Sequencing (NGS) – Full gene sequencing including all exons and splice sites |
| ICD-10-CM Code | E88.49 |
| LOINC Code | 81305-3 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians